Nika Pharmaceuticals, Inc (NIKA) Enterprise Value (2021 - 2023)
Nika Pharmaceuticals' (NIKA) quarterly Enterprise Value came in at -$864.0 in Q4 2023, little changed YoY from -$864.0 in Q4 2022, and up 92.08% on a QoQ basis from -$10910.0 in Q3 2023.
Nika Pharmaceuticals, Inc (NIKA) Enterprise Value (2021 - 2023) Analysis & Trends
Nika Pharmaceuticals (NIKA) has 3 years of Enterprise Value data on file, last reported at -$864.0 in Q4 2023.
- Quarterly Enterprise Value changed 0.0% year-over-year to -$864.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was -$864.0 (changed 0.0% YoY) and the FY2023 annual result came in at -$864.0, changed 0.0% from the prior year.
- Enterprise Value climbed to -$864.0 in Q4 2023, from -$10910.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$83.0 in Q1 2022 to a low of -$11053.0 in Q2 2023.
- A 3-year average of -$3560.2 and a median of -$1528.0 in 2021 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value surged 93.88% — and 2023, when it sank 5272.29%.
- Tracing NIKA's Enterprise Value over 3 years: stood at -$399.0 in 2021, then tumbled by 116.54% to -$864.0 in 2022, then changed by 0.0% to -$864.0 in 2023.
- The last three Enterprise Value figures came in at -$864.0 (Q4 2023), -$10910.0 (Q3 2023), and -$11053.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -864.00 |
| Sep 30, 2023 | -10,910.00 |
| Jun 30, 2023 | -11,053.00 |
| Mar 31, 2023 | -4,459.00 |
| Dec 31, 2022 | -864.00 |
| Sep 30, 2022 | -3,914.00 |
| Mar 31, 2022 | -83.00 |
| Dec 31, 2021 | -399.00 |
| Sep 30, 2021 | -1,699.00 |
| Mar 31, 2021 | -1,357.00 |